Lisa Rojkjaer, M.D.

Lisa Rojkjaer, M.D.

atRigel Pharmaceuticals· In proxies 2022–2025

Pay in FY2022Rigel Pharmaceuticals stock -43.4% the same year

Lisa Rojkjaer, M.D. was paid $0 in FY2022 (Dec). Rigel Pharmaceuticals stock fell 43.4% that year.

Pay$100 in the stock at the end of FY21 → $57
Pay is from the Summary Compensation Table of each Rigel Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rigel PharmaceuticalsPublic company · 4 yr
    • 2022 – Present · 4 yrStock in role +81%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?